Cargando…

Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma

BACKGROUND: Cervical lymph node metastasis of papillary thyroid carcinoma (PTC) is common. However, whether undergoing prophylactic central lymph node (CLN) dissection or lateral lymph node (LLN) dissections to prevent metastasis is still controversial. This study aimed to retrospectively investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Daixing, Zhou, Jing, He, Wei, Peng, Jie, Cao, Yijia, Ren, Haoyu, Mao, Yu, Dou, Yi, Xiong, Wei, Xiao, Qi, Su, Xinliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811970/
https://www.ncbi.nlm.nih.gov/pubmed/29439716
http://dx.doi.org/10.1186/s12957-018-1336-3
_version_ 1783299952153198592
author Hu, Daixing
Zhou, Jing
He, Wei
Peng, Jie
Cao, Yijia
Ren, Haoyu
Mao, Yu
Dou, Yi
Xiong, Wei
Xiao, Qi
Su, Xinliang
author_facet Hu, Daixing
Zhou, Jing
He, Wei
Peng, Jie
Cao, Yijia
Ren, Haoyu
Mao, Yu
Dou, Yi
Xiong, Wei
Xiao, Qi
Su, Xinliang
author_sort Hu, Daixing
collection PubMed
description BACKGROUND: Cervical lymph node metastasis of papillary thyroid carcinoma (PTC) is common. However, whether undergoing prophylactic central lymph node (CLN) dissection or lateral lymph node (LLN) dissections to prevent metastasis is still controversial. This study aimed to retrospectively investigate the risk factors of LLN metastasis in clinical lymph node-negative (cN0) PTC patients. METHODS: We retrospectively studied 783 lymph node-negative (cN0) PTC patients who underwent total thyroidectomy plus CLN dissection and LLN dissection. RESULTS: The rates of CLN and LLN metastases were 68.2 and 47.4%, respectively. Large tumor size (> 20 mm) had a fourfold higher risk of LLN metastasis compared with small tumor size (≤ 20 mm; OR = 4.082, 95% CI 2.646–6.289; P = 0.001). Patients with tumor in the upper lobe had ~ 3-fold higher risk of LLN metastasis compared with patients with tumor in other locations (OR = 2.874, 95% CI 1.916–4.310; P = 0.001). Multifocality and extrathyroidal extension indicated a twofold higher risk of LLN metastasis. Having ≥ 2 CLN metastases dramatically increased the risk of LLN metastasis, compared with those with < 2 CLN metastases (OR = 6.536, 95% CI 4.630–9.259; P = 0.001). CONCLUSIONS: Large tumor size (> 20 mm), tumor located in the upper lobe, multifocality, extrathyroidal extension, and ≥ 2 CLN metastases may increase the risk of LLN metastasis in cN0 PTC patients.
format Online
Article
Text
id pubmed-5811970
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58119702018-02-15 Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma Hu, Daixing Zhou, Jing He, Wei Peng, Jie Cao, Yijia Ren, Haoyu Mao, Yu Dou, Yi Xiong, Wei Xiao, Qi Su, Xinliang World J Surg Oncol Research BACKGROUND: Cervical lymph node metastasis of papillary thyroid carcinoma (PTC) is common. However, whether undergoing prophylactic central lymph node (CLN) dissection or lateral lymph node (LLN) dissections to prevent metastasis is still controversial. This study aimed to retrospectively investigate the risk factors of LLN metastasis in clinical lymph node-negative (cN0) PTC patients. METHODS: We retrospectively studied 783 lymph node-negative (cN0) PTC patients who underwent total thyroidectomy plus CLN dissection and LLN dissection. RESULTS: The rates of CLN and LLN metastases were 68.2 and 47.4%, respectively. Large tumor size (> 20 mm) had a fourfold higher risk of LLN metastasis compared with small tumor size (≤ 20 mm; OR = 4.082, 95% CI 2.646–6.289; P = 0.001). Patients with tumor in the upper lobe had ~ 3-fold higher risk of LLN metastasis compared with patients with tumor in other locations (OR = 2.874, 95% CI 1.916–4.310; P = 0.001). Multifocality and extrathyroidal extension indicated a twofold higher risk of LLN metastasis. Having ≥ 2 CLN metastases dramatically increased the risk of LLN metastasis, compared with those with < 2 CLN metastases (OR = 6.536, 95% CI 4.630–9.259; P = 0.001). CONCLUSIONS: Large tumor size (> 20 mm), tumor located in the upper lobe, multifocality, extrathyroidal extension, and ≥ 2 CLN metastases may increase the risk of LLN metastasis in cN0 PTC patients. BioMed Central 2018-02-13 /pmc/articles/PMC5811970/ /pubmed/29439716 http://dx.doi.org/10.1186/s12957-018-1336-3 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hu, Daixing
Zhou, Jing
He, Wei
Peng, Jie
Cao, Yijia
Ren, Haoyu
Mao, Yu
Dou, Yi
Xiong, Wei
Xiao, Qi
Su, Xinliang
Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma
title Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma
title_full Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma
title_fullStr Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma
title_full_unstemmed Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma
title_short Risk factors of lateral lymph node metastasis in cN0 papillary thyroid carcinoma
title_sort risk factors of lateral lymph node metastasis in cn0 papillary thyroid carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811970/
https://www.ncbi.nlm.nih.gov/pubmed/29439716
http://dx.doi.org/10.1186/s12957-018-1336-3
work_keys_str_mv AT hudaixing riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma
AT zhoujing riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma
AT hewei riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma
AT pengjie riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma
AT caoyijia riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma
AT renhaoyu riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma
AT maoyu riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma
AT douyi riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma
AT xiongwei riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma
AT xiaoqi riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma
AT suxinliang riskfactorsoflaterallymphnodemetastasisincn0papillarythyroidcarcinoma